• top_image


Please see our news in the archive to the right.

MIOCA releases it's 2018 Annual Report

July 11, 2019

We are proud to present MIOCA’s 2018 Annual Report , highlighting another year of continued success as we move the needle to improve the health and quality of life for women and girls with ovarian cancer. As you will see in these pages, again this year MIOCA provided critical support to ovarian cancer survivors and their families directly, while working closely with the scientific, medical, and legislative communities to improve treatment and early detection of ovarian cancer.

MIOCA Reaches $500,000 in Research Grants Awarded in Michigan

May 7, 2019

ANN ARBOR, MI - On World Ovarian Cancer Day, the Michigan Ovarian Cancer Alliance (MIOCA) announces an important milestone in its effort to save lives. Since it started giving grants in 2014, MIOCA has now awarded over a half-million dollars to researchers in Michigan who are finding new ways to improve the early detection and treatment of ovarian cancer.

“MIOCA is pleased to announce three 2019 Geri Fournier Ovarian Cancer Research Award winners, who will each receive $50,000 as part of our efforts to forward ovarian cancer research in our state.” said MIOCA Founder and President, Pam Dahlmann. The Award, named for the Founders’ mother who helped establish MIOCA before her death from ovarian cancer in 2011, was created to recognize the critical research happening right here, in our state, which is often underfunded. “Each and every research project we fund has the potential to result in improved understanding of the disease that will hopefully transform lives for women across Michigan and beyond.”

The State of Michigan is fortunate to have several of the nations’ top ovarian cancer researchers, and this year’s winners represent three institutions who are leading the way in ovarian cancer research. This year’s winners are:

• Rebecca Liu, M.D, Saint Joseph Mercy Health System,
  University of Michigan Rogel Cancer Center
  Michigan Cancer Research Consortium 
  "EASE: Education, Alliance, Solace, and Empowerment for
  Ovarian Cancer Patients."

• Nouri Neamati, Ph.D., University of Michigan College of Pharmacy, and 
  Karen McLean, M.D., Ph.D., University of Michigan Medical School,
  University of Michigan Rogel Cancer Center 
  "Development of STAT3 inhibitors for the treatment of ovarian cancer."

• John Risinger, Ph.D., Michigan State University
  College of Human Medicine 
  "PARP inhibition and non-BRCA DNA damage repair mutation."

For the entire Press Release, click here.

MSU - Kelli Hughes 5K

April 27, 2019

MIOCA would like to sincerely thank Maria Tomovski and her team of students from Michigan State University for hosting the Kelli Hughes 5K this year! The weather was cold but the reason we were all there kept us warm. Go Green!